Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 252996 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 263558 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 278511 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 301383 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 322511 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 325005 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 329425 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 334749 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 335010 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 336338 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 336849 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 338126 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 338547 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 339591 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 345463 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 347096 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 348062 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 353946 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 357071 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 357298 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 372659 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 373652 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 378642 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 385533 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 386164 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 391931 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 392358 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 393221 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 394757 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 397571 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 401833 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 404487 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 405391 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 405920 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 407958 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 408269 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 409409 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 411433 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 416016 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 418017 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 425477 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 425791 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 425978 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 431041 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 431870 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 435936 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 441838 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 447267 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 460996 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 463262 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 463888 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 465837 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 466645 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 468704 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 470206 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 474759 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 475485 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 477481 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 482527 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 502507 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 506649 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 508888 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 521953 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 523679 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 534583 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 538059 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 539926 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 541227 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 543822 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 545111 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 545362 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 547986 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 549932 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 561442 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 561811 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 571814 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 573777 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 588064 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 589803 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 600351 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 600874 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 601853 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 609956 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 619419 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 624703 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 627021 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 627509 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 636555 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 640444 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 662751 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 674813 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 677320 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 683431 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 689466 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 713959 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 830794 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 831981 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 861865 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | 953115 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+CL)- | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 76952 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 85210 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 97671 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 99054 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 108854 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 120045 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 126320 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 127173 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 145399 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 145521 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 156965 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 157459 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 164294 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 172376 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 175546 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 177941 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 180703 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 186250 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 187859 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 195717 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 232234 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 261784 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 268134 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 433616 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 528467 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 535416 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 536110 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 552896 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 575235 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 582771 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 586482 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 589285 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 592008 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 620691 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 650160 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 711598 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 741162 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 756100 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 758219 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 764411 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 796411 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 817915 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 839538 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 869237 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 888464 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 898769 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 911925 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 917148 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 918980 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 926501 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 950534 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 950635 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 960571 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 972660 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1003194 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1056358 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1059795 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1061766 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1072169 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1092243 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1103282 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1116265 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1139868 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1159790 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1166608 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1170795 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1172740 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1175835 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1191324 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1193314 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1210206 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1230316 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1241686 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1242897 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1280467 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1320325 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1345327 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1404452 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1406183 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1406204 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1503243 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1503286 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1608716 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1611632 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1669567 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1699701 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1800840 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | 1869411 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | FRUCTOSE (CAS# 57-48-7); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |